Apogee Therapeutics: No Clinical Efficacy Data, Strong Competition, High Market Cap
Apogee Therapeutics develops therapies for inflammatory autoimmune diseases. Find out why I'm bearish on APGE stock.
Notable Insider Move: PABLO CAGNONI Takes Part In Options Exercise At Incyte, Resulting In $0
What Happened: The latest Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission uncovered CAGNONI, ...
Insider Decision Unfolding At Incyte: Matteo Trotta Exercises Options, Resulting In $0
What Happened: A notable Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission revealed that Trotta, EVP at Incyte, exercised stock options for 0 shares of INCY, resulting in a ...
Hosted on MSN6d
Targeted Oral Drug Plus UV Therapy May Help in Extensive Vitiligo
Combining ultraviolet (UV) phototherapy with the Janus kinase (JAK) inhibitor baricitinib (Olumiant) helped patients with ...